The mechanisms that restrict regeneration and maintain cell identity following injury are poorly characterized in higher vertebrates. Following β -cell loss, 1-2% of the glucagon-producing α -cells spontaneously engage in insulin production in mice. Here we explore the mechanisms inhibiting α -cell plasticity. We show that adaptive α -cell identity changes are constrained by intraislet insulin-and Smoothened-mediated signalling, among others. The combination of β -cell loss or insulin-signalling inhibition, with Smoothened inactivation in α -or δ -cells, stimulates insulin production in more α -cells. These findings suggest that the removal of constitutive 'brake signals' is crucial to neutralize the refractoriness to adaptive cell-fate changes. It appears that the maintenance of cell identity is an active process mediated by repressive signals, which are released by neighbouring cells and curb an intrinsic trend of differentiated cells to change.
H alf a century of research into cell identity determination and maintenance has revealed that adult cells are not terminally differentiated but maintain some plasticity potential even in higher organisms [1] [2] [3] . Spontaneous adult cell-type interconversion is considered a rare event that is highly regulated, often activated exclusively after injury and whose efficiency correlates with mechanisms preserving a specific cell identity 2, 4 . Conversely, our knowledge of the intricate mechanisms that maintain adult cell identity is still limited.
Cell-fate allocation and maintenance 1, 5, 6 result from the activity of transcriptional regulators and epigenetic modifiers that control the constitutive expression of identity genes that become 'locked' due to autoregulatory feed-back loops, stable chromatin modifications [7] [8] [9] or through the action of regulatory signals from the microenvironment in which cells reside. The plasticity potential of a given cell depends on the level of redundancy in which these complex mechanisms operate and on the physiological needs of the corresponding tissue.
Changes in adult cell identity, especially if triggered by stress responses, are a basis for in situ regenerative medicine 10, 11 . In the pancreas of adult mice, following near-total β -cell ablation, 1-2% of glucagon-expressing α -cells and somatostatin-expressing δ -cells spontaneously express insulin, leading to significant β -cell mass regeneration and normoglycaemia 12, 13 . The mechanisms controlling this insulin expression are unknown. We have previously shown that in α -cells, inhibition of the transcription factor Arx and the dimethyltransferase Dnmt1 causes transdifferentiation into insulin + cells irrespective of β -cell loss 14 . However, nothing is known about the control of α -cell identity by extrinsic signals. Here we define the cellular mechanisms that regulate the expression of insulin in glucagon + α -cells after near-total β -cell ablation or insulin action inhibition. We focus on local signals that act as constitutive brakes that limit cell reprogramming. We identified Smoothenedand insulin-signalling pathways in α -cells, and surprisingly also in δ -cells, as regulators of α -cell identity and conversion into insulinproducing cells.
Results

Conversion of α-cells is driven by local signals.
To elucidate the signals that lead to insulin production in α -cells following β -cell loss in mice, we set up a series of islet transplantation experiments ( Fig. 1a ). To prevent allograft rejection, we used severe combined immunodeficient (SCID) mice 15 as hosts for islets isolated from immunocompetent donor mice. In different experimental conditions, islet donor and/or recipient mice also bore the RIP-DTR transgene, which allowed for β -cell ablation following diphtheria toxin administration in either engrafted or pancreatic islets, or both 13 . As a readout for α -cell conversion to insulin production, we assessed the percentage of α -cells that co-expressed glucagon and insulin in the engrafted and/or pancreatic islets of the host. Indeed, cell lineage tracing experiments have shown that these bihormonal cells appearing after β -cell loss are reprogrammed α -cells 13 .
We first transferred wild type (WT) islets (~700) under the kidney capsule of RIP-DTR SCID hosts to ensure normoglycaemia after diphtheria toxin-induced pancreatic β -cell loss (Fig. 1a , Experiment 1 (Exp. 1)). The reverse experiment, in which RIP-DTR islets were transferred into WT normoglycaemic SCID host mice, was also performed ( Fig. 1a, Exp. 2). Ten days post-diphtheria toxin administration, β -cells were efficiently ablated in engrafted RIP-DTR islets ( Supplementary Fig. 1a ). We also transplanted islets from RIP-DTR mice into RIP-DTR SCID hosts (Fig. 1a, Exp. 3). In this experiment, diphtheria toxin treatment led to hyperglycaemia because of β -cell loss in both host and grafted islets ( Fig. 1c , red lines). One month after β -cell ablation, insulin production in α -cells was observed in all three experiments, but only in β -cell-ablated islets (Fig. 1b,d) , irrespective of their location (pancreatic or extra-pancreatic; Supplementary Table 1a ) and glycaemia. Conversion of α -cells was also observed after β -cell ablation in RIP-DTR islets engrafted on the iris (anterior chamber of the eye) of normoglycaemic WT mice (not shown).
The percentage of α -cells producing insulin in β -cell-ablated islets (regardless of their location) was two-fold higher in RIP-DTR K i d n e y K i d n e y K i d n e y P a n c r e a s P a n c r e a s P a n c r e a s SCID mice (1-2% versus 3-4% in SCIDs; refs 12, 13 ). This suggests that the genetic background (SCID) influences α -cell plasticity.
To explore the effect of global 50% β -cell mass loss, we co-transplanted WT and RIP-DTR islets at a 1:1 ratio into WT SCID hosts, either at two separate locations or mixed together at a single location ( Supplementary Fig. 1b , Exp. 4). To distinguish the two types of engrafted islets, we labelled α -cells with yellow fluorescent protein (YFP) in RIP-DTR islets (using Glucagon-rtTA; TetO-Cre; R26-YFP; RIP-DTR mice as donors, in which doxycycline (DOX) triggers the irreversible expression of YFP in α -cells 13 ) and β -cells with mCherry in WT islets (using islets from Insulin-mCherry mice, whose insulin-producing cells constitutively express mCherry). In the twospot transplantation experiment, after diphtheria toxin treatment, no glucagon + cell was insulin + in unablated WT mCherry + islets, whereas 4% of YFP + α -cells produced insulin in β -cell-ablated RIP-DTR ( Supplementary Fig. 1c and Supplementary Table 1a , Exp. 4). This further confirms that α -cells start insulin expression only in massively ablated islets. Similarly, no evidence of α -cell conversion after diphtheria toxin-mediated β -cell ablation was found in WT islets when mixed with RIP-DTR islets, whereas the proportion of YFP-labelled α -cells producing insulin in RIP-DTR islets was similar to the two-spot experiment ( Supplementary Fig. 1c-d ; Supplementary Table 1a , Exp. 4). This suggests that no signals act locally between adjacent β -cell-ablated (RIP-DTR) and unablated (WT) islets, neither from β -cell-ablated RIP-DTR islets that would promote conversion in WT islets with an intact β -cell mass nor from WT islets that would restrict α -cell conversion in nearby RIP-DTR islets.
We next explored the effect of 50% β -cell ablation occurring in every individual islet, either in the pancreas or after transplantation. We used hemizygous RIP-DTR females, in which about 50% of the β -cells express DTR 13 . In these settings (Exp. 5, Supplementary  Table 1a ), mice remained normoglycaemic after diphtheria toxin treatment and no evidence of α -cell conversion was observed ( Supplementary Table 1a ). Partial β -cell loss is thus insufficient to trigger α -cell conversion, even in the more permissive genetic backgrounds (that is, SCID mice).
In summary, these experiments reveal that α -cell conversion occurs only in islets undergoing massive β -cell loss, in an autonomous manner, irrespective of their location or glycaemia. The existence of signals from a putative systemic 'β -cell mass sensor' (Exps. 1-3) or acting at short distance (Exp. 4) is not supported, given that bihormonal cells were only detected in massively β -cell-ablated islets, in hyper-and normoglycaemic mice, and not in islets retaining approximately 50% of their β -cell mass (Exp. 5). Instead, our findings suggest that massive β -cell injury may lead to the release of local signals acting as modulators of α -cell change or maintenance.
Loss of β-cells facilitates insulin expression in α-cells. Why do most α -cells not express insulin after massive β -cell loss?
To explore whether all α -cells can produce insulin, we induced Pdx1 (a β -cell-specific transcription factor) in α Pdx1OE mice. In this quintuple transgenic line ( Fig. 2a ), the administration of DOX causes irreversible expression of Pdx1 and YFP in α -cells ( Fig. 2b) . The in vivo activity of Pdx1 in α -cells leads to the suppression of glucagon 16 (Fig. 2c-e and Supplementary Table 1b ,c) and to insulin expression in a small subset (3%) of α -cells ( Supplementary  Table 1d ). Yet most Pdx1-expressing α -cells produce insulin after β -cell loss induced by treatment with diphtheria toxin or streptozotocin (STZ, a glucose analogue toxic for β -cells) ( Fig. 2f-h and Supplementary Table 1d ), suggesting that all α -cells can produce insulin. α Pdx1OE mice remained hyperglycaemic after β -cell loss, which implies that the insulin-producing α -cells are probably not fully functional (not shown).
We also used DOX to induce another β -cell-specific transcription factor Nkx6.1 in α -cells ( Fig. 2i-l) . This led to Pdx1 induction, glucagon inhibition and insulin expression in most α -cells, but only after β -cell loss ( Fig. 2k,l) .
In summary, in intact islets, β -cell transcription factor activity in α -cells is insufficient to trigger insulin protein production. However, results reveal an intrinsic ability of α -cells to produce insulin when combined with β -cell injury. Thus, β -cell loss enhances the capacity of α -cells to produce insulin.
Antagonistic response of α-cells to β-cell loss. To understand how massive β -cell loss influences the α -cell population, we performed RNA-Seq on native α -cells, α -cells one month after diphtheria toxin-induced β -cell ablation (α DT) and native β -cells. We also profiled α -cells expressing Pdx1, that is, α -cells from Pdx1OE mice (α Pdx1) that lack glucagon expression and α -cells from Pdx1OE mice one month after diphtheria toxin-induced β -cell loss (α Pdx1 + diphtheria toxin) that co-express glucagon and insulin ( Fig. 3a and Supplementary Fig. 2 ). Principal component analyses revealed that α DT, α Pdx1 and α Pdx1 + diphtheria toxin cells retain a strong α -like gene signature, indicating that they are significantly different from native β -cells ( Supplementary Fig. 3a ). We filtered all differentially expressed genes between native α -and β -cells (1,682 and 1,258 genes, respectively; false discovery rate (FDR) < 0.01; fold change (FC) > 2; Supplementary Table 2a ), assessed how they were impacted in α -cells in all conditions (α DT, α Pdx1 and α Pdx1 + diphtheria toxin; Supplementary Table 2 ) and categorized them according to their modulation (up-or downregulated compared to native α -cells; Fig. 3b ,c and Supplementary Fig. 3b ,c). Fifty-nine α -cell genes were downregulated and 140 β -cell genes were upregulated in the α -cells that did not express insulin after diphtheria toxin administration ( Fig. 3b and Supplementary Fig. 3c ), which indicates that α -cells acquire some β -cell identity traits following β -cell loss. Concomitantly, 67 α -cell-enriched genes were further upregulated, reinforcing the α -cell signature. This dual response was also observed in α -cells expressing Pdx1 in islets with intact β -cell mass: 238 β -cell genes were induced (Ins1, Ins2, Gjd2, … ), 153 α -cell genes were downregulated (Gcg, MafB, … ) and 81 α -cell genes were upregulated. Some of the induced β -cell genes (Ins1 and G6pc2) are direct Pdx1 targets. Thirty-five β -cell-enriched genes were induced by diphtheria toxin or Pdx1 (Fig. 3b ).
Although they were not expressed at levels comparable to that of native β -cells, 40% of the β -cell-enriched genes (503 out of 1,258) were upregulated in α -cells expressing Pdx1 when β -cells were ablated ( Fig. 3b ; α Pdx1 + diphtheria toxin). Interestingly, Pdx1 was expressed in these α -cells at levels similar to those observed in β -cells ( Fig. 3c ). Within these 503 upregulated β -cell genes, 233 (46%) were not significantly induced by diphtheria toxin or Pdx1 alone ( Fig. 3d ). Similarly, 238 (66%) of the 361 downregulated α -cell genes in α Pdx1 + diphtheria toxin cells, were not significantly modulated by Pdx1 activity alone or after β -cell loss (Fig. 3b,c and Supplementary Fig. 3c ).
These results indicate that β -cell loss facilitates the expression of β -cell-enriched genes in α -cells. This correlates with the strong induction of insulin in most α Pdx1 cells after β -cell ablation ( Supplementary Fig. 3 ). Massive β -cell ablation decreases the α -cell expression of some α -cell-enriched genes; this is accentuated when combined with Pdx1 induction. Also, other α -cell-enriched genes were further upregulated, indicating that these conditions alter α -cell identity in antagonistic ways.
Insulin deprivation leads to α-cell identity changes. Our results suggest that massive β -cell loss is a requisite for spontaneous α -cell conversion. We therefore hypothesized that active insulin signalling in α -cells may prevent these cells from producing insulin. We assessed whether insulin signalling is compromised in α -cells after β -cell depletion on sorted Venus + α -cells from glucagon-Venus, RIP-DTR mice, five days after β -cell ablation induction (Supplementary **** * Supplementary Table 1b -d for the source data. Fig. 3d,e ). Massive β -cell death triggered a rapid downregulation of insulin-signalling genes in α -cells ( Supplementary Fig. 3e ). Interestingly, insulin-like growth factor 1 (Igf1), an activator of the insulin-signalling pathway, was upregulated in β -cell-depleted islets ( Supplementary Fig. 3f ), probably as a compensatory attempt to maintain insulin/IGF1 signalling in islets. This confirms that insulin signalling is active in α -cells under physiological conditions and is blunted after β -cell loss. Gene set enrichment analyses from RNA sequencing (RNA-Seq) indicate that insulin receptor signalling pathways (PKC activity and PI3K binding) are modulated in α -cells following β -cell ablation ( Supplementary Fig. 3g ).
To investigate whether local insulin deprivation alters α -cell identity, we genetically or pharmacologically impaired insulin/IGF1 receptor signalling in healthy mice. Through DOX administration to α -IR/IGF1R-KO mice, insulin and IGF1 receptors (insulin receptor and IGF1R) were downregulated and YFP was activated in α -cells ( Fig. 4a,b ). This led to Ins1, Nkx6.1 and Pdx1 transcript upregulation in α -cells, although insulin was not detected at the protein level ( Fig. 4c,d) . Therefore, the downregulation of insulin/IGF1 signalling, specifically in α -cells, initiates insulin gene transcription. We speculate that a more efficient inactivation of IR/IGF1R genes in α -cells, and perhaps in all non-β islet cell types, would lead to stronger upregulation of β -cell genes. Furthermore, the observed upregulation of IRS2 probably compensates in part the effects of IR/IGF1R downregulation.
In parallel, we transiently blocked insulin action using the insulin receptor antagonist S961 (Novo Nordisk) [17] [18] [19] , which induces hyperglycaemia and insulin resistance. Healthy Glucagon-rtTA; TetO-Cre; R26-YFP mice were treated with DOX to tag α -cells and then with S961 ( Fig. 4e ). Mice were either analysed during S961 treatment Table S2 . c, Heatmap showing scaled expression (blue, high; white, low) of representative α -or β -cell genes in b and Supplementary Fig. 3c . The gene clustering shown by the dendrogram indicates separated gene clusters with different modulation patterns in each condition analysed, as seen in b and Supplementary Fig. 3 . See Supplementary Table 2 for the source data. Supplementary Table 1e for the source data.
(analysis 1) or after treatment was stopped (analysis 2). When insulin action was inhibited 13, 20 , about 2% of the YFP + -traced α -cells expressed insulin ( Fig. 4f,g, analysis 1 and Supplementary Table 1e ), Pdx1 and Nkx6.1 (Supplementary Fig. 4a-c) . Insulin (Ins1 and Ins2) transcripts were upregulated in α -cells sorted from S961-treated glucagon-Venus mice ( Supplementary Fig. 4d,e ). In contrast, when islets were analysed one month after S961 treatment was stopped ( Fig. 4e , analysis 2; Supplementary Table 1e ), insulin protein became undetectable in α -cells, which suggests that its production had ceased (Fig. 4f,g) .
We next combined STZ-induced partial β -cell loss with the pharmacological inhibition of insulin 20, 21 . One month after STZ treatment, Glucagon-rtTA; TetO-Cre; R26-YFP mice received either Wortmannin (a PI3K inhibitor) or S961, to inhibit the residual insulin signalling (Fig. 4h ). The proportion of α -cells that produce insulin increased following drug treatment compared to mice treated with only STZ (Fig. 4i and Supplementary  Table 1e ). Conversely, α -cell reprogramming was abrogated when STZ treatment was followed by insulin therapy (Fig. 4i Supplementary Table 1f -l for the source data.
and Supplementary Table 1e ), confirming that insulin negatively modulates α -cell plasticity.
When combined with Pdx1 overexpression in α Pdx1OE mice, the number of insulin-producing α -cells were greatly increased in all of the conditions described above ( Supplementary  Fig. 4f-k and Supplementary Table 1d ). Importantly, the number of insulin-negative YFP + α -cells increased again after S961 treatment was stopped ( Supplementary Fig. 4j ), which indicates that α -cells are maintained after discontinuing insulin production.
These observations suggest that β -cell death per se is not required for insulin gene expression in α -cells. Insulin-signalling deprivation promotes insulin production in α -cells in a reversible manner. Therefore, in homeostatic conditions, islet insulin signalling helps maintaining α -cell identity.
Constitutive Smo-mediated signalling restricts α-cell plasticity.
Given that the vast majority of α -cells are apparently unaffected after β -cells loss, we hypothesized that signalling pathways less affected by β -cell injury could convey molecular cues restricting α -cell plasticity, even when insulin signalling is compromised.
Two Supplementary Table 1n -p for the source data.
maintenance in many organs, including the pancreas [23] [24] [25] [26] , where it regulates Pdx1 and Ins expression 27, 28 .
To test whether SmoHh controls α -cell plasticity, we generated Glucagon-rtTA; TetO-Cre; R26-YFP; Smoothened fl/fl (loxP-flanked); RIP-DTR mice (α -Smo-KO) (Fig. 5a ). One-month-old α -Smo-KO mice were DOX-treated to downregulate Smo in α -cells and tag them with YFP ( Supplementary Fig. 5e,f) . The downregulation of α -cell-Smo triggered the downregulation of Gcg and Arx (two α -cell-specific markers; Supplementary Fig. 5g ), suggesting that active SmoHh in α -cells maintains α -cell identity.
Downregulation of α -cell-Smo did not trigger insulin production ( Supplementary Fig. 5h ). Conversely, Smo inactivation along with β -cells loss or S961 treatment (Fig. 5b) increased the percentage of insulin-expressing α -cells ( Fig. 5c,d ; Supplementary Table 1f ). Hence, downregulation of SmoHh facilitates α -cell reprogramming when combined with insulin-signalling inhibition.
We next examined whether insulin-producing α -cells secrete insulin in response to glucose. As these cells are rare, we took advantage of their increased number in the islets of diphtheria toxin-treated α -Smo-KO mice. C-peptide was released in a glucose-responsive manner in the blood of α -Smo-KO mice, one month after β -cell ablation ( Fig. 5e and Supplementary Table 1g ).
To determine the precise contribution of converted α -cells and of escaping β -cells (< 0.5%), we assessed insulin secretion from α -cells in vitro. We isolated islets from α -Smo-KO fl/fl and α -Smo-KO WT/ WT mice after β -cell loss ( Supplementary Table 1h ), sorted YFP + α -cells and re-aggregated them to reconstitute highly purified 'monotypic pseudoislets' (Fig. 5f,g) . We confirmed the increased insulin production in these α -cells by immunofluorescence (Fig. 5h,i and Supplementary Table 1i ) and performed glucosestimulated insulin secretion tests in vitro. Pseudoislets from α -Smo-KO mice secreted C-peptide in a glucose-dependent manner ( Fig. 5j and Supplementary Table 1l ). These results suggest that insulin-producing α -cells are functional and naturally secrete insulin in response to glucose. δ-cells restrict α-cell plasticity. A percentage of δ -cells produce insulin following β -cell loss 12 . As we observed that SmoHh-mediated signalling is active in δ -cells ( Supplementary Fig. 5a-c) , we investigated its putative role in blocking δ -cell plasticity by downregulating it in Somatostatin-rtTA; TetO-Cre; R26-YFP; Smoothened fl/fl ; RIP-DTR mice (δ -Smo-KO) ( Fig. 6a and Supplementary Fig. 5i,j) .
In δ -Smo-KO mice, DOX induces δ -cells Smo downregulation along with YFP-labelling ( Supplementary Fig. 5i,j and Supplementary Table 1m ).
Downregulation of Smo did not affect δ -cell-specific gene expression or induced insulin production ( Supplementary Fig. 5j and Supplementary Table 1n ). After β -cell ablation, the percentage of δ -cells engaging insulin expression was similar in the control and δ -Smo-KO mice ( Supplementary Fig. 5k and Supplementary  Table 1n ). Yet, surprisingly, the number of glucagon + insulin + bihormonal cells was ten-fold higher in mice with Smo downregulated in δ -cells compared to WT mice ( Fig. 6b-d ; Supplementary  Table 1o ). These bihormonal cells were not YFP + -traced, indicating that they were not reprogrammed δ -cells (Fig. 6c ). This suggests a potent δ -cell-mediated non-α -cell-autonomous regulation of α -cell plasticity.
To further explore this non-cell-autonomous regulation of α -cell identity, we generated α + δ -Smo-KO mice (Glucagon-rtTA; Somatostatin-rtTA; TetO-Cre; R26-YFP; Smoothened fl/fl ; RIP-DTR), to inactivate Smo in α -and δ -cells (Fig. 6e ). In this situation, the glucagon + and insulin + bihormonal cells were YFP + -traced (Fig. 6f,g and Supplementary Table 1p ), thus suggesting their α -cell origin.
Pharmacological inhibition of SmoHh with the Hh-signalling inhibitor GANT61 also increased the number of insulin-producing α -cells after β -cell loss ( Supplementary Fig. 5l,m) .
These observations suggest that active SmoHh-mediated signalling in δ -cells is a non-cell-autonomous intra-islet inhibitory signal that restricts α -cell plasticity in β -cell-ablated islets.
Co-ablation of δand β-cells enhances α-cell conversion.
To further confirm that δ -cells act as negative regulators of α -cell plasticity, we generated Somatostatin-Cre; R26-YFP; R26-iDTR; RIP-DTR mice, to co-ablate β -and δ -cells simultaneously ( Supplementary  Fig. 5n ). The loss of β -and δ -cells doubled the proportion of glucagon + and insulin + bihormonal cells ( Supplementary Fig. 5n and Supplementary Table 1q ). This result is compatible with a δ -cellmediated restriction of α -cell plasticity.
Discussion
Maintenance of adult cell identity is a highly dynamic process that depends on the tight convergence of diverse signals whose complexity might be correlated with the regenerative capacity of tissues. The pressure to preserve cell identity is probably stronger in highly specialized cells implicated in vital metabolic processes. Endodermal cells may be intrinsically different, always in a 'regenerative state' , because they are exposed to external insults 1 . Any uncontrolled phenotypic instability could be detrimental and result in the onset of disease.
Our results show that the near-total loss of β -cells triggers simultaneous signals with antagonistic effects on α -cells: they activate insulin production and favour regeneration while also increasing α -cell marker expression, seemingly enforcing the α -cell fate and opposing identity changes.
We have identified paracrine repressive signals that maintain α -cell identity. We show here that α -cell identity is tightly maintained under physiological conditions through the constant repressive influence of local insulin and SmoHh signalling, originating from proximate β -and δ -cells; the inhibition of proximate β -and δ -cells leads to a substantial increase in insulin + α -cell numbers. Thus, in addition to regulating α -cell function through somatostatin and insulin, δ -and β -cells ensure α -cell fate maintenance in a non-α -cell-autonomous manner. Even with dual Smo-Ins downregulation, α -cell conversion is only partially improved, which suggests that α -cell conversion is restricted by the synergistic influence of multiple signals. Recent studies on transcription factors expressed in β -cells (such as Pdx1, Nkx6.1, Nkx2.2 and Pax6) suggest that they are directly involved in repressing non-β -cell genes [29] [30] [31] [32] [33] [34] [35] . The extracellular repressive signals that lock α -cells in their state may therefore be transmitted via such transcriptional repressors.
The maintenance of cell identity detected in the critical, physiologically relevant islets may be much more widespread in differentiated cells, similar to a natural 'tendency' or 'capacity' of adult mature cells, and appears to be subtler than the complete iPSC reprogramming, with several levels of control of switching of cell phenotype.
This has remarkable implications for our comprehension of how the cell identity-differentiation equilibrium is established.
Our results indicate that spontaneous insulin production in α -cells is not simply due to uncontrolled stress-induced insulin gene dysregulation, but is dynamically regulated, representing a meaningful compensatory response to cope with situations of insulin insufficiency.
Importantly, Lee et al. reported the appearance of insulin-resistant α -cells during diabetes 36 . We propose that these insulin-resistant α -cells would be more susceptible to changes in their identity, allowing them to better cope with insulin deficiency. In agreement with such a speculation, bihormonal cells have been reported in the pancreas of diabetic patients 37, 38 . The similarity of insulin-producing α -cells to native β -cells and their level of maturity were not addressed in this study and should be investigated.
In the context of this study, α -cell recruitment into insulin production, encompassing the reduction of glucagon expression, would also be beneficial for diabetics by limiting glucagon secretion and hepatic glucose mobilization, without major metabolic defects caused by α -cell deficit 39, 40 .
In conclusion, we have found that the stability of cell identity is heavily context-dependent and not 'carved in stone' , with several levels of control on the switching of cell phenotype. A physiological input from signalling pathways inside the islet keeps the identity of the cells in homeostasis. The endocrine-cell plasticity detected in this critical organ may be much more widespread in differentiated cells, akin to the natural tendencies of adult mature cells. Maintaining cell identity is therefore an active process of repressive signals released from surrounding neighbour cells, blocking an intrinsic tendency of specialized differentiated cells to modify their phenotype and functional characteristics ( Supplementary Fig. 6 ).
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